Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
Saved in:
| Title: | Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer. |
|---|---|
| Authors: | Shinn E; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. eshinn@mdanderson.org., Zahrieh D; Mayo Clinic, Rochester, MN, USA., DeMichele A; ECOG, University of Pennsylvania, Philadelphia, PA, USA., Zdenkowski N; The University of Newcastle, Callaghan, NSW, Australia., Lemieux J; Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, Canada., Mao J; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bjelic-Radisic V; Helios University Clinic Wuppertal, University Witten/Herdecke Germany, Wuppertal, Germany.; Medical University of Graz, Graz, Austria., Naughton MJ; Ohio State University/Alliance, Columbus, OH, USA., Pfeiler G; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Gelmon K; University of British Columbia, Vancouver, BC, Canada., Balko JM; Vanderbilt University Medical Center, Nashville, TN, USA., Egle D; Medical University of Innsbruck, Innsbruck, Austria.; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Zoppoli G; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Policlinico San Martino IRCCS, University of Genoa, Genoa, Italy., Traina T; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jimenez MM; GEICAM, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Novoa SA; A Coruña University Hospital, A Coruna, Spain., Haddad T; Mayo Clinic, Rochester, MN, USA., Chan A; Breast Cancer Research Centre, Nedlands, WA, Australia., Ring A; The Royal Marsden Hospital, NHS Foundation Trust, East Sussex, UK., Wolff A; Johns Hopkins University/ECOG, Baltimore, MD, USA., Symmans WF; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ponce Lorenzo J; GEICAM, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.; Oncology Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Sabanathan D; Lakeside Specialist Breast Clinic, Nepean Cancer Care Centre, Norwest, NSW, Australia., Burstein HJ; Dana-Farber Cancer Institute, Boston, MA, USA., Nowecki ZI; The Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Pristauz-Telsnigg G; Medical University of Graz, Graz, Austria.; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Brufsky A; University of Pittsburgh Cancer Institute UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Bellet-Ezquerra M; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Foukakis T; Karolinska Institute and University Hospital, Solna, Sweden., Novik Y; New York University, New York, NY, USA., Rubovszky G; National Institute of Oncology, Budapest, Hungary., Singer CF; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Muehlbacher K; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Filho OM; Dana-Farber Cancer Institute, Boston, MA, USA., Goulioti T; Breast International Group, Brussels, Belgium., Law E; Pfizer, Chicago, IL, USA., Partridge AH; Dana-Farber Cancer Institute, Boston, MA, USA., Carey LA; University of North Carolina/Alliance, Chapel Hill, NC, USA., Zoroufy A; Mayo Clinic, Rochester, MN, USA., Hlauschek D; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Fesl C; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Mayer EL; Dana-Farber Cancer Institute, Boston, MA, USA., Gnant M; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.; Medical University of Vienna AT, Vienna, Austria. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Jun; Vol. 211 (2), pp. 385-397. Date of Electronic Publication: 2025 Mar 27. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-025-07653-2 |
